Biotechnology Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis – Enlivex Therapeutics (NASDAQ:ENLV) Read more
Biotechnology FDA Approves Johnson & Johnson’s Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals – Enlivex Therapeutics (NASDAQ:ENLV) Read more
Biotechnology Novo Nordisk’s Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Good News For Sleep Disorder Patients – Takeda’s Therapy Shows Promise In Mid-Stage Study – Takeda Pharmaceutical (NYSE:TAK) Read more
Biotechnology Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 Trial – Tonix Pharmaceuticals (NASDAQ:TNXP) Read more
Biotechnology Vertex Pharmaceuticals’ Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson’s Investigational Drug Meets Primary Goal In Two Studies – Johnson & Johnson (NYSE:JNJ) Read more
Biotechnology ProLynx announces initiation of Phase I/II clinical trial of its DNA-damaging agent PLX038 in patients with rare CNS tumors at the National Cancer Institute (NCI) Read more
Stockmarkets Exclusive-Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth Reuters via biedexmarkets.com Read more